A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Montreal Heart Institute (MHI) clarifies that the operating rooms are all opened and functional. Construction on the operating rooms was initiated in September 2006. The scope of work consisted of replacing the four surgery rooms with seven new rooms equipped with leading edge technologies.
